摘要 |
<p>PCT No. PCT/EP93/01802 Sec. 371 Date Dec. 29, 1994 Sec. 102(e) Date Dec. 29, 1994 PCT Filed Jul. 8, 1993 PCT Pub. No. WO94/01408 PCT Pub. Date Jan. 20, 1994Compounds are described of general formula (I) <IMAGE> (I) and salts and solvates thereof, including physiologically acceptable salts and solvates thereof, in which: Z represents either Het, <IMAGE> or <IMAGE> Het represents an optionally substituted bicyclic or tricyclic ring selected from acricine isoquinolin-1-yl, isoquinolin-3-yl, The novel compounds of formula (I) can sensitize multi-drug resistant cancer cells to chemotherapeutic agents and may be formulated for use in therapy, particularly to improve or increase the efficacy of an anti-tumour drug.</p> |